Disease | cardiomyopathy |
Symptom | C0856169|endothelial dysfunction |
Sentences | 1 |
PubMedID- 23853610 | We foresee that especially a cellular therapy option for b19-induced inflammatory cardiomyopathy, which is associated with a systemic endothelial dysfunction and endothelial damage , could profit from a systemic msc application ensuring an endothelial engraftment. |
Page: 1